Bioactive Peptides from Quinoa (Chenopodium quinoa Willd.) as Modulators of the Gut Microbiome: A Scoping Review of Preclinical Evidence
Nutrients · 14.10.2025 · 17 (20) · 3215
DOI: 10.3390/nu17203215 ↗Kurz gefasst
Scoping Review in der Zeitschrift Nutrients, online erschienen am 14.10.2025. Verfasst von Nicolás Caicedo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Grupo de Investigación en Química y Biología (QUIBIO), Departamento Facultad de Ciencias Básicas, Universidad Santiago de Cali, Cali 760035, Colombia. Hauptthemen laut MEDLINE: Chenopodium quinoa, Gastrointestinal Microbiome, Peptides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad Santiago de Cali, Dirección General de Investigaciones of Universidad Santiago de Cali.
Abstract (Originalsprache)
Background
Gut microbiome dysbiosis is implicated in numerous chronic diseases. While quinoa possesses a rich nutritional profile with prebiotic potential, the specific capacity of its bioactive peptides to modulate gut microbial communities is not well understood. This scoping review systematically maps the preclinical evidence on the gut microbiome modulatory effects of quinoa-derived bioactive peptides to identify mechanisms, characterize their therapeutic potential, and guide future clinical translation.
Methods
Following PRISMA-ScR guidelines, we searched six databases for preclinical studies investigating quinoa-derived peptides or hydrolysates and their effects on gut microbiota.
Results
From 834 records, 19 studies met the inclusion criteria. Quinoa interventions demonstrated consistent effects, with 83% of studies reporting enhancement of beneficial genera and 67% an increase in alpha diversity. Disease-specific microbial signatures were observed; for instance, obesity models showed a reduced Firmicutes/Bacteroidetes ratio, while colitis models exhibited decreased Proteobacteria. Butyrate production was consistently enhanced. Methodologically, peptide generation has evolved from traditional fermentation toward more efficient enzymatic hydrolysis.
Conclusions
Preclinical evidence strongly suggests that quinoa-derived bioactive peptides act as robust, context-dependent modulators of the gut microbiome. These findings position quinoa as a promising functional ingredient for precision gut health interventions, though clinical translation requires standardized preparations and validation in human trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Grupo de Investigación en Química y Biología (QUIBIO), Departamento Facultad de Ciencias Básicas, Universidad Santiago de Cali, Cali 760035, Colombia.
- Grupo de Investigación en Salud Integral (GISI), Departamento Facultad de Salud, Universidad Santiago de Cali, Cali 760035, Colombia.
ORCID-Profile: Nicolás Caicedo, Yamil Liscano, Jose Oñate-Garzón
Förderung
- Universidad Santiago de Cali
- Dirección General de Investigaciones of Universidad Santiago de Cali
Zitieren
APA
Caicedo, N., Liscano, Y., & Oñate-Garzón, J. (2025). Bioactive Peptides from Quinoa (Chenopodium quinoa Willd.) as Modulators of the Gut Microbiome: A Scoping Review of Preclinical Evidence. Nutrients, 17(20), 3215. https://doi.org/10.3390/nu17203215
Vancouver
Caicedo N, Liscano Y, Oñate-Garzón J. Bioactive Peptides from Quinoa (Chenopodium quinoa Willd.) as Modulators of the Gut Microbiome: A Scoping Review of Preclinical Evidence. Nutrients. 2025;17(20):3215. doi:10.3390/nu17203215
BibTeX
@article{Caicedo2025,
author = {Caicedo, Nicolás and Liscano, Yamil and Oñate-Garzón, Jose},
title = {Bioactive Peptides from Quinoa (Chenopodium quinoa Willd.) as Modulators of the Gut Microbiome: A Scoping Review of Preclinical Evidence},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {20},
pages = {3215},
doi = {10.3390/nu17203215}
}
EUVIMED